Potential selection bias in candidates for stereotactic radiotherapy for neovascular AMD.

Christoph EhlkenDaniel BöhringerHansjürgen T AgostiniBastian GrundelMilena Stech

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2017)

SRT in addition to anti-VEGF can be an option in every second patient with nAMD. Due to morphological exclusion criteria, patients eligible for SRT had a better VA and a better clinical response compared to non-eligible patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors
small cell lung cancer
radiation therapy
squamous cell carcinoma
vascular endothelial growth factor
climate change
case report
patient reported